CRO Theorem Clinical Research has formed a strategic alliance with Decision Driver Analytics (DDA) to integrate health economics and outcomes research (HEOR), predictive modeling and definitive analysis to maximize return on investment for pharmaceutical and medical device research programs.

“The clinical studies that may prove a scientific point are really only one aspect of a successful drug or medical device development program,” said John Potthoff, president and CEO of Theorem Clinical Research. “Decision Driver Analytics’ product life cycle value analysis and economic insight help clients make high-value decisions with confidence throughout the entire development process.”

Decision Driver Analytics was founded in 2006 by Elizabeth Brooks, Ph.D., to provide accessible health economics analysis and strategies to drive key product decisions for manufacturers and developers. Brooks has designed numerous health economics models and market development programs. Backed by a team of specialists including health economists, epidemiologists, biostatisticians, medical writers and reimbursement experts, Brooks is known for an ability to make statistical results understandable and actionable.

“Knowing the right answers to key questions at critical decision points in the development process can make the difference between having the latest blockbuster or an expensive failure,” said Potthoff. “We believe this alliance helps drive projects for clients in ways that will achieve both regulatory and marketing success.”